Managing knowledge assets under conditions of radical change: The case of the pharmaceutical industryMinna Allarakhia, Steven Walsh2010-12-22articleTechnovation108 citationsclosedNo readable copy stored yet — this record is metadata only.Intellectual Property and PatentsIntellectual Property LawInnovation and Knowledge ManagementAbstractNo abstract was published for this record.Citations in this libraryStored only when both papers are in the corpus — 108 citations exist upstream.References1984Case Study Research: Design and Methods1960The Problem of Social Cost1996Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology1986Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy1993Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy1986Case study research: Design and methods1994Rules, Games, and Common-Pool Resources1998Can Patents Deter Innovation? The Anticommons in Biomedical ResearchCited by2011How do large multinational companies implement open innovation?2017Managing knowledge assets for open innovation: a systematic literature review2017Economic globalization, entrepreneurship, and development2012When technological discontinuities and disruptive business models challenge dominant industry logics: Insights from the drugs industry2015Exploring the scope of open innovation: a bibliometric review of a decade of research2018The effects of knowledge creation process on organizational performance using the BSC approach: the mediating role of intellectual capital2018Influence of Technological Assets on Organizational Performance through Absorptive Capacity, Organizational Innovation and Internal Labour Flexibility2014Challenges in exploiting open innovation's full potential in the food industry with a focus on small and medium enterprises (SMEs)